Download video

Advancing AI Cancer Drug REC-1245 to Clinical Trials

60 views

Recursion

1 month ago

Advancing AI Cancer Drug REC-1245 to Clinical Trials

Advancing AI Cancer Drug REC-1245 to Clinical Trials

Advances in ADCs for lung cancer at WCLC 2025
1:20
Advances in ADCs for lung cancer at WCLC 2025
by VJOncology
Game-changing Advances in Cancer Treatment
2:47
Game-changing Advances in Cancer Treatment
by OncologyTube
Enfortumab Vedotin (EV-302) + Pembrolizumab vs. Chemo for la\/mUC Phase 3 Update ASCO GU 2025 Powles
2:04
Enfortumab Vedotin (EV-302) + Pembrolizumab vs. Chemo for la\/mUC Phase 3 Update ASCO GU 2025 Powles
by OncologyTube
AACR [2025] RAS Inhibitor Resistance in PDAC Insights - Andrew Aguirre, MD - Dana-Farber
1:15
AACR [2025] RAS Inhibitor Resistance in PDAC Insights - Andrew Aguirre, MD - Dana-Farber
by OncologyTube
Stage IV CANCER Thrivers (Do THIS Next)
10:55
Stage IV CANCER Thrivers (Do THIS Next)
by Dr. Amy - Cancer Researcher \& Cancer Survivor
Exploring ABBV-400 in second-line colorectal cancer treatment
1:10
Exploring ABBV-400 in second-line colorectal cancer treatment
by VJOncology
Recent advances in precision oncology and future implications
4:12
Recent advances in precision oncology and future implications
by COR2ED The Heart of Medical Education
Maximizing Results: 1st \& 2nd Generation Hormone Therapy From The Outset? #MarkScholzMD #AlexScholz
12:43
Maximizing Results: 1st \& 2nd Generation Hormone Therapy From The Outset? #MarkScholzMD #AlexScholz
by Prostate Cancer Research Institute
Clinical Trials for Pancreatic Cancer
21:15
Clinical Trials for Pancreatic Cancer
by Let's Win Pancreatic Cancer
The Top 5 Best Chlorophyll in 2025 - Must Watch Before Buying!
9:39
The Top 5 Best Chlorophyll in 2025 - Must Watch Before Buying!
by Top Best Picks
Advancements in developing inhibitors for non-G12C KRAS mutations
0:38
Advancements in developing inhibitors for non-G12C KRAS mutations
by VJOncology
2nd line chemotherapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)
6:17
2nd line chemotherapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)
by COR2ED The Heart of Medical Education
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
1:34
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
by VJOncology
EMBARK: final OS results of enzalutamide in hrBCR prostate cancer
2:24
EMBARK: final OS results of enzalutamide in hrBCR prostate cancer
by VJOncology
The Science of Secondary Cancer Prevention: What You Must Know
22:46
The Science of Secondary Cancer Prevention: What You Must Know
by Intellectual Medicine
Early results from EVEREST-2 of A2B694, a CAR T therapy, in solid tumors
0:39
Early results from EVEREST-2 of A2B694, a CAR T therapy, in solid tumors
by VJOncology
INTEGRATE IIb: regorafenib plus nivolumab in advanced gastric cancer
1:27
INTEGRATE IIb: regorafenib plus nivolumab in advanced gastric cancer
by VJOncology
Emerging HER2-targeting ADCs in bladder cancer
0:57
Emerging HER2-targeting ADCs in bladder cancer
by VJOncology
03\/31\/2025 - Hi-Risk\/Recurrent\/Advanced PCa Men \& Caregivers
2:06:06
03\/31\/2025 - Hi-Risk\/Recurrent\/Advanced PCa Men \& Caregivers
by AnCan Foundation
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
5:17
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
by Global Resource for Advancing Cancer Education